11 October 2005 by Michael Marx
|
Printable version | Email to a friend |
Six Sigma at Lilly |
|
|
|
|
|
Eli Lilly may be new to using Six Sigma but they put so much research into the methodology before deployment you would have thought it was a new drug. And in fact Six Sigma is the drug to which 200 Black Belts are currently addicted. Once you start up the hellacious hills of hypotheses and down the slippery slopes of statistics towards the marvelous mecca of metrics, it’s hard to stop. A recent article by Jeff Swiatek in The Indianapolis Star revealed the secrets of Six Sigma at Lilly. Here is the overview:
Project Examples
The 2004 Annual Report speaks very highly of Six Sigma and suggests that the company will use the money saved to do more for their customers such as funding clinical trials or broadening their reach so more people can benefit from their products.
Lilly’s deployment of Six Sigma will be one to watch. Their decision to go with Six Sigma was based on years of research from the Six Sigma efforts of a dozen other companies. The financial benefit to the company and shareholders is one thing, but the application of Six Sigma in the pharmaceutical industry has a greater potential to make the world a healthier place. Articles and Links Lilly Breaks Out the Black Belts, Indystar.com, October 10, 2005 Elizabeth H. Klimes, Vice President. Six Sigma, Lilly Website |
|
| Fortune 500 , Pharmaceuticals | |
|
|
|
| posted by Michael Marx at 3:38 PM ET | comments [0] | |
|
|

